Cargando…
Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
Cancer patients represent a vulnerable cohort during the Sars-CoV-2 pandemic. Oncological societies have generated a plethora of recommendations, but precise instructions about routine oncological procedures remain scarce. Here, we report on local COVID-19 protection measures established in an inter...
Autores principales: | Ivanyi, P., Park-Simon, T., Christiansen, H., Gutzmer, R., Vogel, A., Heuser, M., Golpon, H., Hillemanns, P., Haier, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987238/ https://www.ncbi.nlm.nih.gov/pubmed/33759009 http://dx.doi.org/10.1007/s10585-021-10083-1 |
Ejemplares similares
-
Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016) -
Hip and knee arthroplasty: quo vadis?
por: Ho, Jeffery, et al.
Publicado: (2015) -
Quo Vadis Breast Tissue Engineering?
por: Hutmacher, Dietmar W.
Publicado: (2016) -
Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023) -
Biomarkers in SIRS and sepsis: Quo vadis?
por: Novotny, Alexander R.
Publicado: (2010)